Jean-Marc Pascussi

Jean-Marc Pascussi

Auto-generated profile, based on publicly available information

Jean-Marc Pascussi

Centre National de la Recherche Scientifique, UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LDLionel Drocourt
Lionel Drocourt
JOJean-Claude Ourlin
Jean-Claude Ourlin
JPJean-Marc Pascussi
Jean-Marc Pascussi
PMPatrick Maurel
Patrick Maurel
MVMarie-José Vilarem
Marie-José Vilarem
The fully active dihydroxylated metabolite of vitamin D3 induces the expression ofCYP3A4 and, to a lesser extent, CYP2B6 andCYP2C9 genes in normal differentiated primary human hepatocytes. Electrophoretic mobility shift assays and cotransfection in HepG2 cells using wild-type and mutated oligonucleotides revealed that the vitamin D receptor (VDR) binds and transactivates those xenobiotic-responsive elements (ER6, DR3, and DR4) previously identified in CYP3A4, CYP2B6, andCYP2C9 promoters and shown to be targeted by the pregnane X receptor (PXR) and/or the constitutive androstane receptor (CAR). Full VDR response of various CYP3A4 heterologous/homologous promoter-reporter constructs requires both the proximal ER6 and the distal DR3 motifs, as observed previously with rifampicin-activated PXR. Cotransfection of a CYP3A4 homologous promoter-reporter construct (including distal and proximal PXR-binding motifs) and of PXR or CAR expression vectors in HepG2 cells revealed the ability of these receptors to compete with VDR for transcriptional regulation of CYP3A4. In conclusion, this work suggests that VDR, PXR, and CAR control the basal and inducible expression of several CYP genes through competitive interaction with the same battery of responsive elements.

1 August 2000 in Molecular Pharmacology
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
LDLionel Drocourt
Lionel Drocourt
JFJean-Michel Fabre
Jean-Michel Fabre
PMPatrick Maurel
Patrick Maurel
MVMarie-José Vilarem
Marie-José Vilarem
In this report we show that submicromolar concentrations of dexamethasone enhance pregnane X receptor (PXR) activator-mediated CYP3A4 gene expression in cultured human hepatocytes. Because this result is only observed after 24 h of cotreatment and is inhibited by pretreatment with cycloheximide, we further investigated which factor(s), induced by dexamethasone, might be responsible for this effect. We report that dexamethasone increases both retinoid X receptor-α (RXRα) and PXR mRNA expression in cultured human hepatocytes, whereas PXR activators such as rifampicin and clotrimazole do not. Accumulation of RXRα and PXR mRNA reaches a maximum at a concentration of 100 nM dexamethasone after treatment for 6 to 12 h and is greatly diminished by RU486. A similar pattern of expression is observed with tyrosine aminotransferase mRNA. Moreover, the effect of dexamethasone on PXR mRNA accumulation seems to be through direct action on the glucocorticoid receptor (GR) because the addition of cycloheximide has no effect, and dexamethasone does not affect the degradation of PXR mRNA. Furthermore, dexamethasone induces the accumulation of a RXRα-immunoreactive protein and increases the nuclear level of RXRα:PXR heterodimer as shown by gel shift assays with a CYP3A4 ER6 PXRE probe. This accumulation of latent PXR and RXRα in the nucleus of hepatocytes explains the synergistic effect observed with dexamethasone and PXR activators together on CYP3A4 induction. These results reveal the existence of functional cross talk between the GR and PXR, and may explain some controversial aspects of the role of the GR in CYP3A4 induction.

1 February 2003 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
JPJ.M. Pascussi
J.M. Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
LDL. Drocourt
L. Drocourt
PMP. Maurel
P. Maurel
MVM.J. Vilarem
M.J. Vilarem

1 February 2008 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
CDCédric Duret
Cédric Duret
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
MVMarie-José Vilarem
Marie-José Vilarem
PMPatrick Maurel
Patrick Maurel
The expression of many genes involved in xenobiotic/drug metabolism and transport is regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR). These receptors establish crosstalk with other nuclear receptors or transcription factors controlling signaling pathways that regulate the homeostasis of bile acids, lipids, glucose, inflammation, vitamins, hormones, and others. These crosstalks are expected to modify profoundly our vision of xenobiotic/drug disposition and toxicity. They provide molecular mechanisms to explain how physiopathological stimuli affect xenobiotic/drug disposition, and how xenobiotics/drugs may affect physiological functions and generate toxic responses. In addition, the possibility that xenosensors may control other signaling pathways opens the way to new pharmacological opportunities.

15 December 2001 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
JPJean‐Marc Pascussi
Jean‐Marc Pascussi
LDLionel Drocourt
Lionel Drocourt
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
JFJean‐Michel Fabre
Jean‐Michel Fabre
PMPatrick Maurel
Patrick Maurel
MVMarie‐José Vilarem
Marie‐José Vilarem
Although CYP3A induction by dexamethasone has been extensively documented, its mechanism is still unclear because both the role of the glucocorticoid receptor and the ability of dexamethasone to activate the human pregnane X receptor have been questioned. In an attempt to resolve this problem, we investigated the response of CYP3A4 to dexamethasone (10 nm–100 µm) in primary human hepatocytes and HepG2 cells, using a variety of methods: kinetic analysis of CYP3A4 and tyrosine aminotransferase expression, effects of RU486 and cycloheximide, ligand binding assay, cotransfection of HepG2 cells with CYP3A4 reporter gene constructs and vectors expressing the glucocorticoid receptor, pregnane X receptor or constitutively activated receptor. In contrast to rifampicin (monophasic induction), dexamethasone produces a biphasic induction of CYP3A4 mRNA consisting of a low‐dexamethasone component (nmol concentrations) of low amplitude (factor of 3–4) followed by a high‐dexamethasone component (supramicromolar concentrations) of high amplitude (factor of 15–30). We show that the low‐dexamethasone component results from the glucocorticoid receptor‐mediated expression of pregnane X receptor and/or constitutively activated receptor which, in turn, are able to transactivate CYP3A4 in a xenobiotic‐independent manner. At supramicromolar concentrations (>10 µm), dexamethasone binds to and activates pregnane X receptor thus producing the high‐dexamethasone component of CYP3A4 induction. We conclude that, in contrast to the other xenobiotic inducers of CYP3A4, glucocorticoids play a dual role in CYP3A4 expression, first by controlling the expression of PXR and CAR under physiological conditions (submicromolar concentrations) through the classical glucocorticoid receptor pathway, and second by activating the pregnane X receptor under bolus or stress conditions (supramicromolar concentrations).

1 January 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
JPJean-Marc Pascussi
Jean-Marc Pascussi
LPLydiane Pichard-Garcia
Lydiane Pichard-Garcia
MVMarie-Jose Vilarem
Marie-Jose Vilarem
PMPatrick Maurel
Patrick Maurel
Although cytochrome P450 2C9 (CYP2C9) is a major CYP expressed in the adult human liver, its mechanism of regulation is poorly known. In previous work, we have shown that CYP2C9is inducible in primary human hepatocytes by xenobiotics including dexamethasone, rifampicin, and phenobarbital. The aim of this work was to investigate the molecular mechanism(s) controlling the inducible expression of CYP2C9. Deletional analysis ofCYP2C9 regulatory region (+21 to −2088) in the presence of various hormone nuclear receptors suggested the presence of two functional response elements, a glucocorticoid receptor-responsive element (−1648/−1684) and a constitutive androstane receptor-responsive element (CAR, −1783/−1856). Each of these were characterized by co-transfection experiments, directed mutagenesis, gel shift assays, and response to specific antagonists RU486 and androstanol. By these experiments we located a glucocorticoid-responsive element imperfect palindrome at −1662/−1676, and a DR4 motif at −1803/−1818 recognized and transactivated by human glucocorticoid receptor and by hCAR and pregnane X receptor, respectively. Identification of these functional elements provides rational mechanistic basis for CYP2C9induction by dexamethasone (submicromolar concentrations), and by phenobarbital and rifampicin, respectively. CYP2C9 appears therefore to be a primary glucocorticoid-responsive gene, which in addition, may be induced by xenobiotics through CAR/pregnane X receptor activation.